A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is caused by immune-mediated destruction of insulin-producing β-cells. Insufficient control of autoreactive T cells by regulatory T cells (Tregs) is believed to contribute to disease pathogenesis, but changes in Treg function are difficult to quantify because of the lack of Treg-exclusive markers in humans and the complexity of functional experiments. We established a new way to track Tregs by using a gene signature that discriminates between Tregs and conventional T cells regardless of their activation states. The resulting 31-gene panel was validated with the NanoString nCounter platform and then measured in sorted CD4+CD25hiCD127lo Tregs from children with T1D and age-matched control subjects. By using biomarker discovery analysis, we found that expression of a combination of six genes, including TNFRSF1B (CD120b) and FOXP3, was significantly different between Tregs from subjects with new-onset T1D and control subjects, resulting in a sensitive (mean ± SD 0.86 ± 0.14) and specific (0.78 ± 0.18) biomarker algorithm. Thus, although the proportion of Tregs in peripheral blood is similar between children with T1D and control subjects, significant changes in gene expression can be detected early in disease process. These findings provide new insight into the mechanisms underlying the failure to control autoimmunity in T1D and might lead to a biomarker test to monitor Tregs throughout disease progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently the only way to confidently quantify human Tregs is to use a panel of different markers and then carry out parallel functional [381], gene expression [382], and/or epigenetic analyses [383, 384].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [382]
Citations
Cites
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291 · cited 1×
“Previous attempts to define specific markers of human Tregs focused on comparing CD25 and CD25(2) cells (11,12,21,22), thereby introducing bias toward identifying T-cell activation/memory markers rather than Tregs.”
BackgroundReich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,032
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861 · cited 1×
“Whether peripheral T1D Tregs are able to suppress effector cell proliferation is unclear (4,5,23).”
BackgroundWilliams, L. M., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1437 · Cited by 853 · cited 1×
“Two rounds of Gene Set Enrichment Analysis were performed with and without a cutoff (750-count difference between Tregs and Tconvs) and including publicly available data sets of mouse (9,10) or human (11–15) Treg/ Tconv gene expression profiles.”
MethodBattaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736 · cited 1×
“Whether peripheral T1D Tregs are able to suppress effector cell proliferation is unclear (4,5,23).”
BackgroundFetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans
Mold, J. E., Venkatasubrahmanyam, S., Burt, T. D., Michaëlsson, J., Rivera, J. M., Galkina, S. A., Weinberg, K., Stoddart, C. A., & McCune, J. M. (2010) · Science · doi:10.1126/science.1196509 · Cited by 444 · cited 1×
“Previous attempts to define specific markers of human Tregs focused on comparing CD25 and CD25(2) cells (11,12,21,22), thereby introducing bias toward identifying T-cell activation/memory markers rather than Tregs.”
BackgroundPlasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmüller, U., Baron, U., Olek, S., Bluestone, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003099 · Cited by 428 · cited 2×
“Some evidence points to impaired Treg function in T1D (4–7), possibly related to differentiation into cells producing interleukin (IL)-17 (6) or interferon-g (7), but in vitro suppression assays may not reflect in vivo function because cells are removed from their inflammatory environment.”
BackgroundMultiparameter Immune Profiling of Operational Tolerance in Liver Transplantation
Martínez-Llordella, M., Puig-Pey, I., Orlando, G., Ramoni, M., Tisone, G., Rimola, A., Lerut, J., Latinne, D., Margarit, C., Bilbao, I., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01621.x · Cited by 374
CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
Long, S. A., & Buckner, J. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003224 · Cited by 294 · cited 3×
“The proportion of CD25CD127FOXP3 Tregs in blood of subjects with T1D is normal (3); we confirmed this in a pediatric cohort (including similar levels of FOXP3 protein expression) and further showed that ex vivo Tregs from subjects with T1D have a demethylated TSDR.”
BackgroundInfluential
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR
Zemmour, D., Zilionis, R., Kiner, E., Klein, A. M., Mathis, D., & Benoist, C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0051-0 · Cited by 384
“Biclustering heatmap of published activated/resting signatures 12,66 (Bottom).”
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Hull, C. M., Peakman, M., & Tree, T. I. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4377-1 · Cited by 194
“…frequency of IL-17-producing cells in CD45RA−CD25intFOXP3low T cells vs NDB, which displayed reduced suppressive function Altered Treg transcriptome Pesenacker et al (2016) [37] With recent-onset T1D; with established T1D; NDB Identified a panel of genes that are differentially expressed in…”
BackgroundLakhter, A. J., Pratt, R. E., Moore, R. E., Doucette, K. K., Maier, B. F., DiMeglio, L. A., & Sims, E. K. (2018) · Diabetologia · doi:10.1007/s00125-018-4559-5 · Cited by 173
Metadata
- Authors
- Pesenacker, A. M., Wang, A. Y., Singh, A., Gillies, J., Kim, Y., Piccirillo, C. A., Nguyen, D., Haining, W. N., Tebbutt, S. J., Panagiotopoulos, C., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- McGill University (CA)
- Broad Institute (US)
- Corresponding author
- Levings, Megan K.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-01-19
- Volume
- 65
- Issue
- 4
- Pages
- 1031-1039
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2305631593
- Cited by
- 69
- References
- 36
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 5 · 2019: 9 · 2018: 8 · 2017: 5 · 2016: 5
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes for Health Research (MOP-115199)
- Canucks for Kids Foundation
- Genome BC
- Genome Quebec
- Stemcell Technologies
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, regulatory T cells, gene expression signatures, biomarkers, new-onset diabetes, children, TNF receptor 2, Foxp3, autoimmunity, disease progression monitoring, NanoString nCounter
- MeSH terms
- Adult, Cells, Cultured, Child, Diabetes Mellitus, Type 1, Humans, Male, Mass Screening, Sensitivity and Specificity, Biomarkers, Autoimmunity, Case-Control Studies, Age of Onset, Disease Progression, T-Lymphocytes, Regulatory, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.